Dipna Pharmachem Limited (BOM:543594)
India
· Delayed Price · Currency is INR 8.88
+0.38 (4.47%)
At close: Mar 10, 2026
Dipna Pharmachem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,066 | 1,249 | 1,643 | 999.27 | 727.55 | 310 | Upgrade
|
| Revenue | 1,066 | 1,249 | 1,643 | 999.27 | 727.55 | 310 | Upgrade
|
| Revenue Growth (YoY) | -41.07% | -23.99% | 64.46% | 37.35% | 134.70% | 1.51% | Upgrade
|
| Cost of Revenue | 886.33 | 1,137 | 1,579 | 954.95 | 686.13 | 295.85 | Upgrade
|
| Gross Profit | 179.89 | 111.71 | 64 | 44.33 | 41.42 | 14.15 | Upgrade
|
| Selling, General & Admin | 4.59 | 4.53 | 5.14 | 0.81 | 0.7 | 4.25 | Upgrade
|
| Other Operating Expenses | 135.71 | 69.8 | 24.41 | 20 | 18.97 | 5.83 | Upgrade
|
| Operating Expenses | 140.42 | 74.44 | 29.73 | 20.92 | 19.73 | 10.15 | Upgrade
|
| Operating Income | 39.47 | 37.27 | 34.27 | 23.41 | 21.7 | 4 | Upgrade
|
| Interest Expense | -23.02 | -23.2 | -20.12 | -9.66 | -6.06 | -3.01 | Upgrade
|
| Interest & Investment Income | 0.13 | 0.13 | 0.03 | 0.06 | 0.09 | 0.1 | Upgrade
|
| Other Non Operating Income (Expenses) | 12.13 | 0 | 0.02 | 0 | 0.02 | -0.53 | Upgrade
|
| Pretax Income | 28.71 | 14.2 | 14.19 | 13.81 | 15.74 | 0.55 | Upgrade
|
| Income Tax Expense | 8.23 | 4.46 | 3.34 | 4.69 | 4.07 | 0.31 | Upgrade
|
| Net Income | 20.48 | 9.74 | 10.85 | 9.12 | 11.67 | 0.24 | Upgrade
|
| Net Income to Common | 20.48 | 9.74 | 10.85 | 9.12 | 11.67 | 0.24 | Upgrade
|
| Net Income Growth | 146.32% | -10.25% | 19.02% | -21.85% | 4721.77% | -58.98% | Upgrade
|
| Shares Outstanding (Basic) | 24 | 24 | 12 | 12 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 24 | 12 | 12 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 40.32% | 97.02% | 0.50% | 7042.07% | - | - | Upgrade
|
| EPS (Basic) | 0.86 | 0.41 | 0.90 | 0.76 | 69.46 | 1.44 | Upgrade
|
| EPS (Diluted) | 0.86 | 0.41 | 0.90 | 0.76 | 69.46 | 1.44 | Upgrade
|
| EPS Growth | 75.54% | -54.44% | 18.42% | -98.91% | 4721.77% | -58.98% | Upgrade
|
| Free Cash Flow | -140.91 | -92.15 | -54.31 | -209.86 | 27.99 | -24.38 | Upgrade
|
| Free Cash Flow Per Share | -5.95 | -3.88 | -4.50 | -17.49 | 166.59 | -145.09 | Upgrade
|
| Gross Margin | 16.87% | 8.94% | 3.89% | 4.44% | 5.69% | 4.57% | Upgrade
|
| Operating Margin | 3.70% | 2.98% | 2.09% | 2.34% | 2.98% | 1.29% | Upgrade
|
| Profit Margin | 1.92% | 0.78% | 0.66% | 0.91% | 1.60% | 0.08% | Upgrade
|
| Free Cash Flow Margin | -13.22% | -7.38% | -3.31% | -21.00% | 3.85% | -7.86% | Upgrade
|
| EBITDA | 39.6 | 37.39 | 34.44 | 23.52 | 21.76 | 4.07 | Upgrade
|
| EBITDA Margin | 3.71% | 2.99% | 2.10% | 2.35% | 2.99% | 1.31% | Upgrade
|
| D&A For EBITDA | 0.13 | 0.11 | 0.17 | 0.12 | 0.06 | 0.07 | Upgrade
|
| EBIT | 39.47 | 37.27 | 34.27 | 23.41 | 21.7 | 4 | Upgrade
|
| EBIT Margin | 3.70% | 2.98% | 2.09% | 2.34% | 2.98% | 1.29% | Upgrade
|
| Effective Tax Rate | 28.66% | 31.40% | 23.54% | 33.98% | 25.88% | 56.00% | Upgrade
|
| Revenue as Reported | - | 1,249 | 1,643 | 999.34 | 727.66 | 310.15 | Upgrade
|
| Advertising Expenses | - | 0.07 | 0.13 | 0.04 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.